Our Recent Posts

Catalyst OrthoScience Announces 5-8 Year Data Reporting Significant Functional Improvement and Pain Reduction for Anatomic Total Shoulder Arthroplasty

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Nice shout-out from JobsOH for Cleveland HeartLab!

ltodia
Nov 20, 2015
1 min read

Please see the “Opportunities and Innovations in Ohio’s BioHealth Industry” video below. Companies like these are why we’ve been investing in the Midwest and specifically in Ohio for 15 years.

https://www.youtube.com/watch?v=lTsapNALw-A

Catalyst OrthoScience Announces 5-8 Year Data Reporting Significant Functional Improvement and Pain Reduction for Anatomic Total Shoulder Arthroplasty

OrthAlign, Inc. Announces First Cases Using Lantern® Hip; The Next Evolution in Total Hip Replacement Technology

OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip

Nice shout-out from JobsOH for Cleveland HeartLab!

Comentarios

©2024 by Mutual Capital Partners